Seeing beyond the limit: Detect residual disease and assess treatment response
Summary of analytical and clinical data for Signatera™, the first ctDNA assay custom-built for MRD detection and treatment response.
Summary of analytical and clinical data for Signatera™, the first ctDNA assay custom-built for MRD detection and treatment response.